Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

To main content To sitemap To news Check availability details

Use of immunomodulatory DNA oligonucleotides in treatment of Atopic dermatitis

Reference number
Coordinator INDEX PHARMACEUTICALS AB
Funding from Vinnova SEK 1 825 000
Project duration September 2016 - December 2018
Status Completed

Last updated 19 February 2021

Reference number 2016-01335

Page statistics